MOH — authorised 22 February 2019
- Marketing authorisation holder: ACCORD HLTHCARE INC
- Status: likely_approved
MOH authorised Busulfex on 22 February 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 22 February 2019.
ACCORD HLTHCARE INC holds the Israeli marketing authorisation.